Should the 14‐day rule for embryo research become the 28‐day rule?

Appleby, John B and Bredenoord, Annelien L (2018) Should the 14‐day rule for embryo research become the 28‐day rule? EMBO Molecular Medicine. ISSN 1757-4676

[img]
Preview
PDF (emmm.201809437.full)
emmm.201809437.full.pdf - Published Version

Download (209kB)

Abstract

The “14‐day rule”—broadly construed—is used in science policy and regulation to limit research on human embryos to a maximum period of 14 days after their creation or to the equivalent stage of development that is normally attributed to a 14‐day‐old embryo (Hyun et al, 2016; Nuffield Council on Bioethics, 2017). For several decades, the 14‐day rule has been a shining example of how science policy and regulation can be developed with interdisciplinary consensus and applied across a number of countries to help fulfil an ethical and practical purpose: to facilitate efficient and ethical embryo research. However, advances in embryology and biomedical research have led to suggestions that the 14‐day rule is no longer adequate (Deglincerti et al, 2016; Shahbazi et al, 2016; Hurlbut et al, 2017). Therefore, should the 14‐day rule be extended and, if so, where should we draw a new line for permissible embryo research? Here, we provide scientific, regulatory and ethical arguments that the 14‐day rule should be extended to 28 days (or the developmental equivalent stage of a 28‐day‐old embryo).

Item Type:
Journal Article
Journal or Publication Title:
EMBO Molecular Medicine
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/1300/1313
Subjects:
ID Code:
126824
Deposited By:
Deposited On:
10 Aug 2018 13:02
Refereed?:
No
Published?:
Published
Last Modified:
02 Aug 2020 05:45